SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-16-000154
Filing Date
2016-04-29
Accepted
2016-04-29 18:47:42
Documents
1
Period of Report
2016-04-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 8133
  Complete submission text file 0000891293-16-000154.txt   9617
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPACELABS MEDICAL INC 15220 NE 40TH ST REDMOND WA 98053
Business Address
NUDELMAN PHILLIP M PHD (Reporting) CIK: 0001041084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 161609129